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SÍNDROME METABÓLICO Y FACTORES ASOCIADOS
EN NIÑOS Y ADOLESCENTES DE UN MUNICIPIO
BRASILEÑO
Resumen
Introducción: Los factores asociados al Síndrome metabólico
(SM) han sido ampliamente estudiados en adultos, pero aún son
poco explorado en niños y adolescentes
Objetivo: Identificar la superioridad de SM y los factores aso-
ciados en niños y adolescentes. 
Métodos: Se trata de estudio transversal, con 540 niños de 7 a
14 años de edad. Los datos socioeconómicos, demográficos, esti-
lo de vida e historia familiar de enfermedades crónicas fueron
informados por la persona y/o responsable y registrados en
cuestionario estructurado. Fueron realizadas dosificaciones
bioquímicas (glicemia en ayuno, triglicérides, lipoproteína de
alta densidad reducida, lipoproteína de muy baja densidad, ho-
mocisteina y cisteina), evaluación antropométrica y verificación
de la presión arterial. La SM fue definida de acuerdo con los cri-
terios del The National Cholesterol Education Program Adult
Treatment Panel III adaptado por Ferranti. Se utilizó regresión
de Poisson como técnica estadística para identificar los factores
asociados a la SM.
Resultados: La superioridad de la SM fue del 12,8%, siendo a
lipoproteína de alta densidad reducida (58,2%) el componente
más frecuente, seguido por la hipertrigliceridemia (41,8%), pre-
sión arterial aumentada (29,1%), circunferencia de la cintura
aumentada (26,7%) e hiperglicemia (7,2%). Fue observada aso-
ciación entre SM y exceso de peso (RP: 2,2 [1,22-3,95]), escolari-
dad paterna (RP: 2,19 [1,10-4,37]), concentración sérica de la li-
poproteína de muy baja densidad (RP: 1,08 [1,04-1,11]) y
concentraciones séricas simultáneamente aumentadas de homo-
cisteina y cisteina (RP: 2,58 [1,32-5,04]).
Conclusiones: La superioridad de SM es elevada en niños y
adolescentes y se encuentra aumentada en paciente con exceso
de peso, mayor escolaridad paterna, concentraciones séricas au-
mentadas de la lipoproteína de muy baja densidad, y elevación
simultánea de los niveles séricos de homocisteína y cisteína.
(Nutr Hosp. 2014;29:865-872)
DOI:10.3305/nh.2014.29.4.7206
Palabras clave: Síndrome metabólico X. Obesidad. Homocis -
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Abstract
Background: the risk factors associated to metabolic syn -
drome (MS) have been extensively studied in adults, but in chil-
dren and adolescents it is poorly explored.
Objective: To identify the prevalence of MS and associated
factors in children and adolescents.
Methods: A cross-sectional study with 540 children and
adolescents from 7 to 14 years of age. The socioeconomic, demo-
graphic and lifestyle data and the family history of chronic dise-
ases were reported by the individual and/or guardian and
recorded in a structured questionnaire. Biochemical tests
(fasting blood glucose, triacylglycerols, reduced high-density
lipoprotein, very-low-density lipoprotein, homocysteine and
cysteine), an anthropometric assessment and a blood pressure
measurement were performed. MS was defined according to the
criteria of The National Cholesterol Education Program Adult
Treatment Panel III adapted by Ferranti. A Poisson regression
was used to identify the factors statistically associated with MS.
Results: The MS prevalence was 12.8%, in which the most
frequent component was a decreased high-density lipoprotein
level (58.2%), followed by hypertriglyceridemia (41.8%),
elevated blood pressure (29.1%), increased waist circumference
(26.7%) and hyperglycemia (7.2%). Associations between meta-
bolic syndrome and overweight [prevalence ratio (PR): 2.2
(1.22-3.95)], father education [PR: 2.19 (1.10-4.37)], serum very
low-density lipoprotein concentration [PR: 1.08 (1.04-1.11)] and
concomitantly increased serum homocysteine and cysteine
concentrations [PR: 2.58 (1.32-5.04)] were observed.
Conclusions: The MS prevalence is high in children and
adolescents and it is increased in patients with overweight,
higher father education, increased serum very-low-density lipo-
protein concentrations and a concomitant serum homocysteine
and cysteine high levels. 
(Nutr Hosp. 2014;29:865-872)
DOI:10.3305/nh.2014.29.4.7206
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Introduction
The occurrence of obesity in childhood and adoles-
cence has increased in the last 4 decades and has
become an important health problem in many regions
worldwide1.
The prevalence of overweight and obesity has
increased considerably between the years 1974/75 and
2008/09 in Brazilian children and adolescents. During
this period, the occurrence of obesity increased by
nearly 6-fold, and overweight tripled in children of
both genders. In adolescents, the problem expanded
with greater intensity among males2. Currently, the
prevalences of overweight and obesity in Brazil are
33.5% and 14.3% in children and 20.5% and 4.9% in
adolescents, respectively2.
Excessive weight gain in childhood and adolescence
may favor the waist circumference (WC) increase and
the development of metabolic disorders such as hyper-
tension, hyperglycemia, elevated serum triacylglyc-
erols (TG) and decreased high-density lipoprotein1.
The combination of 3 or more of these components
constitutes metabolic syndrome (MS), a condition that
is well established as an additional complication of
obesity in adults and is also currently becoming
common among children and adolescents. This
syndrome is considered an important risk factor for the
development of cardiovascular disease and diabetes in
children, adolescents and adults3,4.
MS is well defined, but there is no global consensus
for its diagnosis, making it difficult to compare the
prevalence rates of MS between different regions5. The
criteria used for diagnosis in adults are also being
adopted in children and adolescents, after adjusting for
the pediatric reference standards1,5. However, there is
no consensus for the adoption of this practice among all
researchers of the subject1,5.
Although excess weight6-8 and insulin resistance
have often been associated with MS, the broad range of
determining factors has hampered a complete under-
standing of the pathogenesis of MS.
Other factors have been associated with MS in chil-
dren and adolescents, such as gender8, low birth
weight, fetal macrosomia, low levels of maternal and
paternal education7,9, physical inactivity, the time spent
on sedentary activities7,9, a family history of obesity,
diabetes, hypertension and an unhealthy diet9.
Elevated serum homocysteine concentrations have
also recently been associated with MS in adults10-12.
However, little is known regarding the relationship of
these factors with the occurrence of MS in children.
Thus, although the study of the factors associated with
MS in adults has raised the interest of Brazilian
researchers, few studies have sought to identify the pre -
sence of MS and the alterations that may increase the risk
of developing the disease in children and adolescents.
This article aimed to identify the prevalence and risk
factors associated to MS in children and adolescents.
Methods
Study design and sample
This cross-sectional study examined a random
sample of 540 children and adolescents aged between 7
and 14 years old from the municipality of Recôncavo
Baiano. The data were obtained from a broader study
entitled “Strategy to promote a healthy lifestyle and
diet at school and at home - an interventional study”
and have a power of 80% to identify the prevalence of
MS in this population with a significance level of 5%.
Inclusion and exclusion criteria and losses
The study included schoolchildren from 7 to 14
years of age who were enrolled in public or private
schools in the urban area of the municipality of
Mutuípe, state of Bahia, Brazil, in 2006.
Pregnant adolescents, nursing mothers or school-
children with some type of disability or physical
trauma that prevented obtaining anthropometric data;
those previously diagnosed with diabetes, liver disease
or chronic kidney disease; and those using medication
to control blood pressure (BP) and lipid profile or
medication that alters serum homocysteine and
cysteine levels were excluded from the study.
Students from the enrollment list who moved to
other municipalities or who were not found were
considered losses.
Ethics Statement
The study was approved by the Research Ethics
Committee of the School of Nutrition, Federal Univer-
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sity of Bahia (number 03/2006). The students’ partici-
pation in the study was subject to written permission
from parents and/or guardians, who signed an informed
consent form after being informed about the objectives
of the study.
Data collection
The data were collected by nutritionists and by labo-
ratory technicians duly trained in the standard tech-
niques adopted in this study.
Socioeconomic and demographic data, lifestyle and
family history of morbidity
The data regarding socioeconomic status, demo-
graphic information and lifestyle and the family history
of morbidity were reported by the individuals and/or
guardians and recorded in a structured questionnaire.
An index was developed to assess the socioeco-
nomic status that considered the number of rooms in
the house, the number of people living in the household
and the occupation of the household head. Each va -
riable that composed the socioeconomic index
comprised answers ranging from 0 (worst condition) to
4 points (best condition). Thus, the index had a
minimum score of 0 and a maximum of 12 points.
Those who obtained scores above the median were
considered to have an adequate socioeconomic status
(reference = 0), while the others were deemed to have
an inadequate socioeconomic status (risk = 1).
The parental educational level was categorized with
regard to years of study (≤ 8 years = 0 and > 8 years = 1).
The variables that characterized alcohol consump-
tion (no = 0, yes = 1), smoking (no = 0, yes = 1), the
number of daily hours spent watching TV, playing
videogames or using the computer (< 2 hours = 0, ≥ 2
hours = 1) and the practice of regular exercise outside
of school (yes = 0, no = 1) were adopted to assess the
lifestyle of the participants. The presence (1) of chronic
non-communicable diseases such as obesity, dyslipi-
demia and hypertension in first-degree relatives of the
participant, as well as their absence (0), were consi -
dered as the family history of morbidity.
Anthropometric data
Weight was measured on a digital scale (Filizola®)
with a 150 kg capacity and 100 g precision. Weighing
was performed with the participant barefoot, wearing
lightweight clothing and with an empty bladder. The
individual remained standing on the scale platform
with the body weight equally distributed between the
feet13. Height was measured with a portable
stadiometer (Leicester Height Measure). The measure-
ment was performed with the participant barefoot,
without accessories or caps on the head, in an upright
position with arms hanging at the sides of the body,
shoulders relaxed, heels together and with the head
positioned in the Frankfort plane13.
The Waist Circumference (WC) was measured in
the horizontal plane at the midpoint between the last
right rib and the iliac crest using an inelastic fiberglass
tape14.
All of the anthropometric measurements were
repeated by different evaluators, and the maximum
acceptable variations between measurements were as
follows: weight = 0.1 kg, height = 0.1 cm and WC = 0.5
cm. The mean of the measurements was adopted as the
final measure.
Body mass index (BMI)
The anthropometric diagnosis was based on body
mass index per age (BMI/A), considering the growth
curves for each gender and the cutoff points proposed
by the World Health Organization (WHO) (2007)15.
The student was classified as having excess weight
when he/she was overweight (BMI/A ≥ 85th percentile)
or obese (BMI/A ≥ 97th percentile).
Blood pressure
The Blood Pressure (BP) was obtained using an
aneroid sphygmomanometer with a cuff appropriate
for the arm circumference and age of the participant
following the techniques proposed by the IV Brazilian
Guidelines on Hypertension16. The measurements were
performed in duplicate, and the mean of the 2 readings
was used as the final measure.
The BP was classified according to the criteria
proposed by The Fourth Report on the Diagnosis, Eva -
luation, and Treatment of High Blood Pressure in Chil-
dren and Adolescents, considering gender, age and
height percentile as follows: normal BP (systolic or
diastolic BP < 90th percentile), prehypertensive (90th to
95th percentiles), hypertensive (BP ≥ 95th percentile)17.
Biochemical tests
An 8 ml blood sample was collected after a 12-hour
fasting period to determine the lipid profile, the fasting
blood glucose level and the levels of homocysteine and
cysteine. Total cholesterol (TC), very-low-density
lipoprotein cholesterol (VLDL-C), high-density
lipoprotein cholesterol (HDL-C), triacylglycerols (TG)
and fasting blood glucose levels were determined with
the enzymatic calorimetric method, while the low-
density lipoprotein cholesterol (LDL-C) level was
obtained using the Friedewald equation [LDL-C = TC
– HDL-C – (TG/5)]. To classify MS, the categorization
of the TG, HDL-C and blood glucose levels was
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performed according to the cutoff points proposed by
Ferranti18.
Due to the lack of reference values for VLDL-C in
children and adolescents, this parameter was included
as a continuous variable in the final model.
Serum homocysteine and cysteine levels were
measured using high-performance liquid chromato -
graphy with an isocratic elution and fluorimetric detec-
tion, which is considered the gold standard for this
procedure19. These analyses were performed at the
Laboratory of Inborn Errors of Metabolism of the
Federal University of São Paulo. Because the reference
values for homocysteine and cysteine in healthy chil-
dren and adolescents have not been established, the
80th percentile was adopted as a cutoff point based on
the values of the sample itself.
Definition of MS
The criterion proposed by The National Cholesterol
Education Program Adult Treatment Panel III (NCEP /
ATP III) and adapted by Ferranti et al (2004) was used
to characterize the metabolic disorders (MS)18. The
criterion entails the presence of 3 or more of the
following alterations in the same individual: WC ≥ 75th
percentile, BP ≥ 90th percentile, TG ≥ 100 mg/dL,
HDL-C < 50 mg/dL and blood glucose > 100 mg/dL.
Due to the lack of reference values for the classifica-
tion of WC in Brazilian children and adolescents, the
classification of the participants in this study was
performed according to percentile values of the
sample, considering gender and age8,18.
Statistical analysis
The characterization of the study population was
conducted through descriptive analysis using preva-
lence. A Poisson regression was used to identify the
factors associated with MS. The variables with a p-
value < 0.20 in the bivariate analysis were tested in the
multivariate model, and the variables that presented the
adopted level of significance of p < 0.05 remained in
the final model. The Akaike Information Criterio
(AIC) and the Pseudo-R2 were used to evaluate, respec-
tively, the full model adjustment and explanation
ability. The analyses were performed using the Stata
software (version 12.0).
Results
Characterization of the population, the prevalence
of MS and its components
Table I contains the socio-demographic and lifestyle
characteristics of the study participants. There was a
predominance of females (57.6%) and those who were
more than or equal to 10 years old (69.9%). A lower
level of education was observed in 91.4% of fathers
and 82.8% of mothers.
Regarding the lifestyle of the participants, smoking
and alcohol consumption were observed in 0.8% and
12.8% of participants, respectively. Moreover, 24.5%
of the students regularly engaged in sports, while
80.1% spent 2 or more hours daily in sedentary
activity.
Table II has the clinical and biochemical data of the
children and adolescents in the study. Excess weight,
hyperhomocysteinemia and hypercysteinemia were
identified in 20.5%, 20.5% and 24.7% of the partici-
pants, respectively. Among the alterations that
compose MS, there was a higher prevalence of low
concentrations of HDL-C (58.2%), followed by hyper-
triglyceridemia (41.8%), elevated BP (29.1%), high
WC (26.7%) and hyperglycemia (7.2%).
The prevalence of MS identified among the students
in the study was 12.8%. However, the presence of at
least 1 component of MS was detected in 85.7% of the
participants, and 2 components were found in 32.5% of
the students (fig. 1).
Factors associated with MS
Table III has the results of the bivariate analysis of
the relationship between MS and the covariates of
interest in this study. Statistically significant associa-
tions between MS and excess weight (p < 0.001),
higher father education (p = 0.01), hyperhomocys-
Table I
Socio-demographic and lifestyle characteristics of the
children and adolescents fo the municipality of Mautuipe,
state of Bahia, Brazil, 2006
Variables Categorization n (%)
Sex Females 289 57.6
Males 213 42.4
Age < 10 years 151 30.1
≥ 10 years 351 69.6
Father’s educational level ≤ 8 years 380 91.4
> 8 years 36 8.6
Mother’s educational level ≤ 8 years 396 8.28
> 8 years 82 17.2
Socioeconomic index Inadequate 243 48.4
Adequate 259 51.6
Smoking Yes 40.8
No 498 99.2
Alcohol consumption Yes 64 12.8
No 438 87.2
Practice of regular exercise Yes 122 24.3
No 380 75.7
Time spent TV*,
videogames or computer < 2 hours/day 98 19.9
≥ 2 hours/day 394 80.1
*Tv: Television.
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teinemia (p < 0.01), hypercysteinemia (p < 0.01),
concomitantly elevated serum homocysteine and
cysteine concentrations (p < 0.01), increased VLDL-C
levels (p < 0.001) and a family history of obesity (p =
0.046) were identified.
The Poisson regression analysis results for MS and
the exposure variables are shown in table IV. Excess
weight contributed to an increase of 120% in the preva-
lence of MS compared to the prevalence observed in
normal-weight individuals (p < 0.01). The prevalence
of MS in students whose fathers studied for more than 8
years was 119% (p = 0.026) higher than that in children
and adolescents whose fathers had a lower education
level. An increase of 1 mg/dL in the mean VLDL-C
value increased the prevalence of MS by 8% (p <
0.001), and the prevalence of MS was 158% higher in
students who had serum homocysteine and cysteine
concentrations concomitantly elevated compared to
that in children and adolescents with adequate concen-
trations of these biochemical parameters (p < 0.001).
This final model fitted well to the data, showing an
AIC (Akaike’s information criterion) improvement
from 373.47 for the reduced model (including the
outcome variable MS and the independent variable
weight excess) to 287.42 when adjusted by the inde-
pendents variables father education level, VLDL-c
value and homocysteine and cysteine high levels (full
model), indicating little loss of information when
included all the variables of the full model. This final
model tested, containing all the exposure variables
associated with MS, demonstrated a good explanatory
power, measured by the pseudo-R2, indicating that
these variables explain 15% of the cases of MS in the
population studied (table IV).
A loss was registered in 38 cases (7.04%), of which 37
were not located and 1 was not tested biochemically.
Discussion
The prevalence of MS in this study was 12.8%,
which indicates a clinically relevant condition in the
pediatric population. This study also found a higher
incidence of MS among children with excess weight,
higher paternal education, elevated serum very low-
density lipoprotein concentrations and concomitantly
elevated serum homocysteine and cysteine levels.
Prevalence of MS and its components
The most frequent component of MS was low HDL-
C, followed by hypertriglyceridemia, while hyper-
glycemia was the least frequent. These results confirm
the findings of Kelishadi et al (2008)9, which are in
agreement regarding the ranking of the MS compo-
nents; however, these authors found a higher preva-
lence of low HDL-C (72%) and a lower prevalence of
elevated BP (7%) and hyperglycemia (4%).
The early identification of abnormal parameters
associated with MS is essential to determine the neces-
sary treatment, to prevent the accumulation of MS
Table II
Clinical and biochemical data of the children and
adolescents of the municipality of Mutuípe, state of Bahia,
Brazil, 2006
Variables Categorization n (%)
BMI/A* Normal 399 79.5
Excess weight 103 20.5
Homocysteine < p 80 379 75.5
≥ p 80 123 24.5
> p 80 378 75.3
≥ p 80 124 24.7
Components of the MS**
Wasit circumference < p 75 370 73.7
≥ p 75 132 26.3
Blood pressure < 90 356 70.9
≥ p 90 146 29.1
Fasting glucose < 100 mg/dl 466 92.8
≥ 100 mg/dl 36 7.2
HDLc*** < 50 mg/dl 292 58.2
≥ 60 mg/dl 210 41.8
Triacylglycerols < 100 mg/dl 292 58.2
≥ 100 mg/dl 210 41.8
*BMI/A: Body mass indez/age. **MS: Metabolic syndrome.
***HDLc: High density lipoprotein cholesterol.
Fig. 1.—Prevalence of meta-
bolic syndrome (MS) and
number of components of the
MS in children and adoles-
cents.
1 Component 2 Components ≥ 3 Components (MS)
85.70%
32.50%
12.80%
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components and consequently to prevent the develop-
ment of MS in childhood. The presence of at least 1 of
the identified components among schoolchildren in
this study was greater than that found in other regions
of the world9,20,21, while the presence of 2 components
occurred less frequently than that observed in children
and adolescents from Portugal20 and more frequently
that that observed in Chinese children21.
The prevalence of MS in children and adolescents
(12.8%) found in this study was similar to that recorded
Tabla III
Bivariate analysis of the Poisson regression for metabolic syndrome and the covariates of interest.
Mutuípe, state of Bahia, Brazil, 2006
Variables Categorization PR SE* CI 95% p
Sex Females 1 – – –
Males 1.2 0.30 (0,73-1,96) 0,472
Age < 10 years 1 – – –
≥ 10 years 1.29 0.37 (0.73-2.27) 0.377
Father’s educational level ≥ 8 years 1 – – –
> 8 years 3.09 1.01 (1.62-5.88) 0.001
Mother’s educationa l level ≥ 8 years 1 – – –
> 8 years 1.51 0.45 (0.84-2.69) 0.164
Socioeconomic index Adequate 1 – – –
Inadequate 0.83 0.21 (0.51-1.35) 0.451
Alcohol consumption No 1 – – –
Yes 1.42 0.47 (0.74-2.72) 0.290
Practice of regular exercise Yes 1 – – –
No 1.39 0.44 (0.74-2.61) 0.303
Time TV** and videogames < 2 hours/day 1 – – –
≥ 2 hours/day 1.15 0.38 (0.60-2.21) 0.668
BMI/A*** Normal 1 – – –
Excess weight 3.42 0.86 (2.09-5.58) 0.000
HCY† < p 80 1 – – –
≥ p 80 2.25 0.57 (1.37-3.69) 0.000
CYS†† < p 80 1 – – –
≥ p 80 2.08 0.53 (1.27-3.43) 0.004
HCY + CYS Normal 1 – – –
HCY ou CYS ≥ p 80 1.99 0.61 (1.10-3.63) 0.024
HCY + CYS ≥ p 80 2.73 0.82 (1.52-4.92) 0.001
VLDLc††† Continuous variable 1.08 0.01 (1.05-1.10) 0.000
Family history of obesity No 1 – – –
Yes 1.67 0.43 (1.01-2.77) 0.046
Family history dyslipidemia No 1 – – –
Yes 0.99 0.26 (0.59-1.67) 0.98
Family history of hypertension No 1 – – –
Yes 1.39 0.45 (0.74-2.61) 0.304
*SE: standard error. **TV: Television. ***BMI/A: Body mass index/age. †HCY: Homocysteine. ††CYS: Cysteine. †††VLDLc: Very low den-
sity lipoprotein cholesterol.
Tabla IV
Factors associated with metabolic syndrome in children and adolescents of the municipality
of Mutuípe, state of Bahia, Brazil, 2006*
Variables PR SE* CI 95% p
Weight excess 2.2 0.66 (1.22-3.95) 0.009
Father’s educational level (> 8 years) 2.19 0.77 (1.10-4.37) 0.026
VLDLc*** (continuous variable) 1.08 0.02 (1.04-1.11) 0.000
Homocysteine ou cysteine ≥ p80 1.74 0.60 (0.89-3.42) 0.107
Homocysteine e cysteine ≥ p 80 2.58 0.88 (1.32-5.04) 0.000
*Poisson regression analysis; **SE: Standard Error. ***VLDLc: Very low density lipoprotein cholesterol. AIC (Akaike’s information criterion)
of the reduced models (excesso weight = 373.47, excesso weight + father’s educational level 0 306.8; excesso weight + father’s educational level +
VLDLc = 291.13); AIC of full model = 287.42; Pseudo R2 of the full model = 0.15.
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by researchers who adopted the same classification
criteria in the United States (12.7%)22, Korea (13.4%)1
and Iran (14.1%)9. In the studies performed in Brazil 23
and in Portugal20, the occurrence of MS was higher
(22.6% and 34.9%, respectively) than that observed in
the present study, however, the majority of participants
in those studies were obese, which may have favored
these results. Notably, lower frequencies (6.6% and
2.6%) of MS have been reported in China4,21.
Ferranti et al (2006)22 determined that the prevalence
of MS in American adolescents increased from 9.2% to
12.7% in the period from 1988-94 to 1999/2000
according to the National Health and Nutrition Exami-
nation Surveys (NHANES) and that this growth is
partly related to the higher occurrence of abdominal
obesity. The prevalence of MS has remained stable in
normal-weight individuals but has grown considerably
among those with excess weight (31.2% to 38.6%) in
the same period. Thus, these results indicate that the
increases in overweight and obesity in children
observed in recent years may favor the development of
MS in children and adolescents and, therefore, the
earlier onset of cardiovascular disease and diabetes.
Factors associated with MS
Other studies4,6-8,21 have also reported an association
between excess weight and MS in children and adoles-
cents. MS was 5.1 and 11.1 times more prevalent
among adolescents who were overweight and obese,
respectively, than those with a normal weight for their
height, as reported by Stabelini et al (2012)8. These
results indicate that MS may be associated with excess
weight in children and adolescents.
The results of several studies conducted to date have
not provided consistent evidence of the association of
MS with an individual’s life situation. In that context, a
higher parental education level was associated with
MS, unlike other studies that found no association9 or
that found an association between MS and less educa-
tion7,24. Regarding these results, it is possible to believe
that the higher father education level can indicate a
better acquisitive power and, consequently, an easier
access to industrialized foods at home and at scholar
environment and to consumer goods (television, elec-
tronics products) which favor a sedentary lifestyle.
This study is one of the few that evaluates the rela-
tionship between MS and VLDL-C. From the results, it
can be postulated that high serum VLDL-C concentra-
tions lead to hypertriglyceridemia, which results from
the increased synthesis of VLDL-C or from reduced
triglyceride lipolysis25,26. Consequently, the high levels
of VLDL-C also favor a reduction in serum HDL-C
levels, which favors the development of MS26,27.
Finally, it is worth mentioning that this study breaks
new ground by seeking to identify the relationship
between MS and serum homocysteine and cysteine
concentrations in children and adolescents. Although few
studies have been performed with this age group, recent
studies have reported the association between concomi-
tantly elevated serum homocysteine and cysteine
concentrations and obesity28,29 and increased WC28 in chil-
dren and adolescents. The concomitant elevation of
serum homocysteine and cysteine levels was also associa -
ted with reduced HDL-C levels in adults30.
Therefore, homocysteine and cysteine high levels
may enhance the MS development in children and
adolescents. Although this study did not observe a
significant association between MS and serum homo-
cysteine and cysteine concentrations alone, hyperho-
mocysteinemia was found to be associated with hyper-
tension and weight gain in children and adolescents by
Ganji and Kafai (2003)31 and with increased WC32,
hypertension31, low HDL-C 30 and hyperglycemia32 in
adults. Recent studies10-12 were also able to identify the
occurrence of MS in adults with elevated serum homo-
cysteine concentrations.
Although the causal mechanism between hyperho-
mocisteinemia, hypercysteinemia and MS is not
completely clarified, some pathophysiological mecha-
nisms have been suggested to explain the role of these
parameters in the onset of the metabolic disorders that
compose the SM. The causal relation between hyper-
homocisteinemia and hypertension have been associa -
ted to the arterial stiffening, endothelial dysfunction
due the nitric oxide decreased action, serum folate
decrease and insulin resistance33. Hyperhomocys-
teinemia may also promote the HDL-c reduction34 and
the tryacilglycerol increase35, because it seems to be
responsible for the Apolipoprotein AI factor transcrip-
tion inhibition involved in the HDL-c synthesis and for
the SREBP-1 (sterol regulatory element-binding
protein 1) expression increase which is important to the
TG synthesis34, 35.
The association between hypercysteinemia and
overweight and increased WC may be explained by the
fatty acid stimulation synthesis promoted by the
cysteine high levels, resulting in adipose tissue accu-
mulation, mainly in the abdominal region. Further-
more, in adipocytes, the cysteine suffers autoxidation
and liberates hydrogen peroxide, which acts as a lipo -
lysis inhibitor29. The results indicate that the combina-
tion of both elevated parameters may promote an
increase in the prevalence of MS in children and
adolescents.
One of the limitations of the present study can be
attributed, in particular, to the nature of its design,
which does not allow assessing causality. However,
statistical analyses that are appropriate for the study
design were adopted as an initial step to identify the
factors associated with MS in children and adolescents.
Another limitation is related to the absence of an inter-
national consensus for classifying MS, which restricts
comparison of the results between studies that adopt
different criteria. Therefore, one of the most commonly
used criteria to diagnose MS was selected20, using
cutoff points adapted to the age group studied.
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The prevalence of MS is high in children and adoles-
cents and is increased in patients with excess weight,
higher father education, increased serum concentra-
tions of very low-density lipoprotein and a concomi-
tant elevation of serum homocysteine and cysteine
levels. These findings highlight the need to identify the
components of MS and the factors associated with this
disease early and, thereby, to control existing alte -
rations and prevent the development of MS in the pe -
diatric population.
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